Muhammad Ishrat Husain
Biographic Data
| ID | 7180003 |
|---|---|
| NAME | Muhammad Ishrat Husain |
| GIVEN NAMES | Muhammad Ishrat |
| FAMILY NAME | Husain |
| SIGNATURE | HUSAIN M I |
| AFFILIATIONS | Centre for Addiction and Mental Health |
| ORCID | 0000-0001-5771-5750 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Lived Experiences of Bipolar Disorder and Family Caregiving in Pakistan
Background: Bipolar disorder (BD) is associated with substantial disability and caregiver burden.In Pakistan, the prevalence is unusually high, and limited mental health services place families at the centre of care.Cultural and religious beliefs strongly shape how the illness is recognized, understood, and managed.This study explored how individuals living with BD and their caregivers understand and navigate the illness within this context. Meth…
A mixed methods analysis of existing assessment and evaluation tools (AETs) for mental health applications
Introduction: Mental health Applications (MH Apps) can potentially improve access to high-quality mental health care. However, the recent rapid expansion of MH Apps has created growing concern regarding their safety and effectiveness, leading to the development of AETs (Assessment and Evaluation Tools) to help guide users. This article provides a critical, mixed methods analysis of existing AETs for MH Apps by reviewing the criteria used to evalu…
Beyond Psilocybin
There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics remain limited. A comprehensive scoping review on the us…
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances
Although several studies have well described the characteristics of people who use psychedelics alongside their motivations and beliefs, little research has examined the preferences surrounding the source of psychedelic substances. In an anonymous online survey, we collected data from 6,379 consumers of 11 different psychedelic substances from 85 different countries, exploring their preferences and perceptions on natural and synthetic psychedelic…
Global Trends in Psychedelic Microdosing
Despite psychedelic microdosing being a growing practice, the research on the topic is still in its infancy. While several studies have described the characteristics, motivations and practices of microdosers, the differences between individuals that only microdose and those that use both micro and macrodoses of psychedelics remain unexplored. In an online survey, we collected data of 6193 psychedelic consumers of which 2488 were microdosers of up…
Psychosocial and pharmacological interventions for personality disorders in low- and middle-income countries
Personality disorders (PDs) have a global prevalence of 7.8% and are associated with increased rates of morbidity and mortality. Most research on PDs has been conducted in High Income Countries (HICs). We conducted a systematic review to investigate the effectiveness of psychosocial and pharmacological interventions for personality disorders (PDs) in individuals from Low- and Middle-Income Countries (LMICs.) We systematically searched MEDLINE, Em…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…
A Group Parenting Intervention for Depressed Fathers (LTP + Dads)
The trial was registered on Clinicaltrials.gov on 9 December 2020 (identifier: NCT04660253)
The Impact of Covid-19 on Psychiatric Emergency and Inpatient Services in the First Month of the Pandemic in a Large Urban Mental Health Hospital in Ontario, Canada
The World Health Organization characterized COVID-19 (coronavirus disease 2019) as a pandemic on March 11, 2020 (WHO). Within a couple of days, all Canadian provinces announced the implementation of social distancing measures. We evaluated the immediate effect of COVID-19 on psychiatric emergency and inpatient services in Canada's largest psychiatric hospital in the first month of the pandemic. We extracted data from the electronic medical record…
No prominent works on this page.
A Group Parenting Intervention for Depressed Fathers (LTP + Dads)
The trial was registered on Clinicaltrials.gov on 9 December 2020 (identifier: NCT04660253)
The Impact of Covid-19 on Psychiatric Emergency and Inpatient Services in the First Month of the Pandemic in a Large Urban Mental Health Hospital in Ontario, Canada
The World Health Organization characterized COVID-19 (coronavirus disease 2019) as a pandemic on March 11, 2020 (WHO). Within a couple of days, all Canadian provinces announced the implementation of social distancing measures. We evaluated the immediate effect of COVID-19 on psychiatric emergency and inpatient services in Canada's largest psychiatric hospital in the first month of the pandemic. We extracted data from the electronic medical record…
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
BACKGROUND: Psilocybin is being studied for use in treatment-resistant depression. METHODS: In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant depression to receive a single dose of a proprietary, synthetic formulation of psilocybin at a dose of 25 mg, 10 mg, or 1 mg (control), along with psychological support. The primary end point was the change from baseline to week 3 in the total score on the Montgomery-Å…
Psychosocial and pharmacological interventions for personality disorders in low- and middle-income countries
Personality disorders (PDs) have a global prevalence of 7.8% and are associated with increased rates of morbidity and mortality. Most research on PDs has been conducted in High Income Countries (HICs). We conducted a systematic review to investigate the effectiveness of psychosocial and pharmacological interventions for personality disorders (PDs) in individuals from Low- and Middle-Income Countries (LMICs.) We systematically searched MEDLINE, Em…
A mixed methods analysis of existing assessment and evaluation tools (AETs) for mental health applications
Introduction: Mental health Applications (MH Apps) can potentially improve access to high-quality mental health care. However, the recent rapid expansion of MH Apps has created growing concern regarding their safety and effectiveness, leading to the development of AETs (Assessment and Evaluation Tools) to help guide users. This article provides a critical, mixed methods analysis of existing AETs for MH Apps by reviewing the criteria used to evalu…
Beyond Psilocybin
There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics remain limited. A comprehensive scoping review on the us…
Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances
Although several studies have well described the characteristics of people who use psychedelics alongside their motivations and beliefs, little research has examined the preferences surrounding the source of psychedelic substances. In an anonymous online survey, we collected data from 6,379 consumers of 11 different psychedelic substances from 85 different countries, exploring their preferences and perceptions on natural and synthetic psychedelic…
Global Trends in Psychedelic Microdosing
Despite psychedelic microdosing being a growing practice, the research on the topic is still in its infancy. While several studies have described the characteristics, motivations and practices of microdosers, the differences between individuals that only microdose and those that use both micro and macrodoses of psychedelics remain unexplored. In an online survey, we collected data of 6193 psychedelic consumers of which 2488 were microdosers of up…
Lived Experiences of Bipolar Disorder and Family Caregiving in Pakistan
Background: Bipolar disorder (BD) is associated with substantial disability and caregiver burden.In Pakistan, the prevalence is unusually high, and limited mental health services place families at the centre of care.Cultural and religious beliefs strongly shape how the illness is recognized, understood, and managed.This study explored how individuals living with BD and their caregivers understand and navigate the illness within this context. Meth…
Psychiatry (6 works) · Medicine (5 works) · Psychology (5 works) · Psychedelics and Drug Studies (4 works) · Anxiety (3 works) · Clinical Psychology (3 works) · Hallucinogen (3 works) · Mental health (3 works) · Psilocybin (3 works) · Chemical synthesis and alkaloids (2 works)